INS and myocardial infarction: DIGAMI 1 and DIGAMI 2 evaluated insulin therapy (using glucose-insulin-potassium infusions) after a myocardial infarction and the studies came to opposite conclusions (DIGAMI 1: benefit; DIGAMI 2: no benefit) [34, 35].